EBOS Group Limited/Announcement
EBOS Group Limited logo

SPH Notice - Sybos Holdings Pte Limited ("Sybos")

Substantial Holder Notice3 June 2025EBOHealthcare

Disclosure of ceasing to have substantial holding
Section 279, Financial Markets Conduct Act 2013


To: NZX Limited

and

To: EBOS Group Limited ("EBOS")

Date this disclosure made: 3 June 2025

Date last disclosure made: 29 May 2025

Date on which substantial holding ceased: 3 June 2025

Substantial product holder(s) giving disclosure

Full name(s): Sybos Holdings Pte Limited ("Sybos")

Summary of previous substantial holding

Class of quoted voting products: Ordinary shares in EBOS (NZX, ASX: EBO)

Summary for Sybos

For last disclosure,—

(a) total number held in class: 36,698,002

(b) total in class: 203,225,074

(c) total percentage held in class: 18.058%

For current holding after ceasing to have substantial holding,—

(a) total number held in class: 9,957,825

(b) total in class: 203,225,074

(c) total percentage held in class: 4.900%

Details of transactions and events giving rise to relevant event

Details of the transactions or other events requiring disclosure:

On 28 May 2025, Sybos entered into a block trade agreement (the "Agreement") with UBS New

Zealand Limited ("UBS") under which Sybos appointed UBS to manage and underwrite the sale of

26,740,177 ordinary shares in EBOS currently held by Sybos for NZ$35.50 per share (or

NZ$949,276,283.50 in aggregate). A copy of the Agreement was attached to Sybos's substantial

product holder notice to the NZX dated 29 May 2025. Settlement of this sale has now occurred.

Additional information
Address(es) of substantial product holder(s): C/- Russell McVeagh, Level 30 Vero Centre, 48

Shortland Street, Auckland 1010, New Zealand

Contact details:


Name: David Raudkivi, Russell McVeagh

Phone: 09 367 8000

Email: david.raudkivi@russellmcveagh.com

Name of any other person believed to have given, or believed to be required to give, a disclosure

under the Financial Markets Conduct Act 2013 in relation to the financial products to which this

disclosure relates: UBS New Zealand Limited

Certification

I, Thomas Zuellig, director of Sybos, certify that, to the best of my knowledge and belief, the

information contained in this disclosure is correct and that I am duly authorised to make this disclosure

by all persons for whom it is made.

Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.

Other issuers discussed similar conditions around this time

Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.